Join ConQuest 2025 | ComplianceQuest User Conference | April 8–10, Clearwater Beach, FL
Discover your potential savings with our ROI Calculator
Product Lifecycle Management
Enable cross-functional collaboration and accelerate your product lifecycle with a cloud-based platform for innovation
Design Process and Quality System Development Tools in Product Lifecycle
Design Quality
Get full visibility over your product design processes and make collaboration easy to get your products to market faster, compliantly
Design Quality: Connecting Design to Documentation
Complaints Management
Transform customer complaints to valuable sources of insights for continuous improvement through smart automations and integrated regulatory reporting
Challenges with Triage and Investigation in Complaints Management Process
Document and Learning Management
Say goodbye to paper! Modernize your processes with connected document, training, and change management
Manufacturing Challenges and Industry Trends Towards Digital Transformation
Quality Management
Transform quality into an enabler: boost efficiency, increase satisfaction, and trim costs with a fully connected, AI-powered quality management solution
Frost Radar for Quality Management Systems Names ComplianceQuest Leader
Risk Management
Enable risk-based thinking throughout your quality processes with a fully integrated risk management solution
Automation of the Risk Management Lifecycle with AI and Analytics
Supplier Management
Increase supplier performance, reduce costs, and streamline your supply chain with integrated supplier quality and collaboration tools
The Ultimate Guide to Next-Generation Supplier Management [e-Book]
Safety Management
Identify and minimize safety events. Prevent accidents, safeguard workers, and ensure their well-being and health
Safety Essentials: Key ‘Must-have’ Components for Safety Management at Any Enterprise
Environment and Sustainability
Proactively and accurately monitor and measure your company’s impact on the environment to improve performance and reach your environmental and sustainability targets
Environmental & Sustainability Management
Electronic and Automated Approach to Audit Management
Managing the Tools of the Trade
Manage Operational Risk Tracking, Evaluation, Mitigation and monitoring
Leveraging CAPA for Continuous Improvement
Ensure your laboratory is compliant with systematic and efficient laboratory investigations
Incident Reporting and Management
Organization, Collaboration and Governance for Efficient Changes
Conduct smart management review meetings with a tower of data to improve your quality and safety systems
Gain 360 degree vision into enterprise wide Safety risks
Enhance Safety and Compliance with Smarter Chemical Management
Ensuring Quality across Departments & Locations
Partner With Suppliers And Vendors To Improve Quality And Safety
Create Loyalty by Addressing Customer Complaints Smartly
Bring Consistency to Permit Practices
Make it easy for your people to manage, track and analyze environmental and sustainability metrics
Bring higher quality products to market quicker with design controls, projects & DHF
Streamline Permit Management and Ensure Compliance
When Learning Propels Organizational Growth
Improve efficiency, productivity, and compliance with a solution designed for today's diverse workforce learning styles
Strategically manage the complete lifecycle of your product
Efficient Waste Management for Compliance & Sustainability
Relevant Information within reach - Always.
Assuring Quality Products and Services
Self-guided Product Tours
Product Demo Videos
Pricing
ComplianceQuest covers the whole spectrum of customers, industries and regions across the world. Whether it is a small, medium or enterprise sized manufacturer, companies choose ComplianceQuest for its end-to-end Product Lifecycle, Quality, Safety and Supplier Management Solutions.
Salesforce
Leveraging AI to Create a Safer Workplace Environment
Why an EHS Solution Built on Salesforce Works Better Than One Built on AWS or Azure
CQ Platform
Humans: The Real Superheroes of Artificial Intelligence (AI) in Quality Management
Recent Blogs
Recent Infographics
Recent Case Studies
Featured Case Study
ComplianceQuest Medical Devices QMS Success Stories eBook
Recent Checklists
Featured Checklist
Complaint Handling Process for MedTech and Life Science Companies
Course Offerings
Recent CQ Guides
Featured CQ Guide
Datasheets
Brochures
Demo Center
Podcasts
Podcast
Aphria (now Tilray) CIO talks about their implementation of ComplianceQuest, Rootstock and Salesforce
Videos
Recent Webinars
Webinar
Unlocking the Value of Complaints
Recent Whitepapers
Whitepaper
Why You Need to Digitally Transform Your QMS
Recent Compliance
Compliance
The Ultimate Guide to ISO/IEC 17025:2017 Compliance
Infographic
Safety Technology Trends to Watch in 2023 (Infographic)
Recent Toolkits
Featured Toolkit
Data-driven Safety – Strategic Resources for Monitoring of Key Performance Indicators
Events and Webinars
Events
Upcoming Webinars
Featured Event
Interphex
01 Apr, 2025
New York, NY
About
About ComplianceQuest
Transform to a fully connected business with a next-generation AI-powered Product Lifecycle, Quality, Safety, and Supplier management platform, built on Salesforce.
Our connected suite of solutions helps businesses of all sizes increase product, quality, safety, and supplier as they bring their products from concept to customer success.
Meet the Leadership Team
Careers
Where Your Career Takes Flight: Join our dynamic team and be part of an innovative, collaborative and rewarding workplace culture.
Corporate Citizenship
Impact Through Action: How the ComplianceQuest team supports social causes and community engagement
Customers & Testimonials
Newsroom
The Pulse of ComplienceQuest: Our newsroom shares stories of innovation, progress, and change
Partners
Stronger Together: How our partnerships drive success and innovation
Upcoming Events
Understanding the importance of Phase 1 and Phase 2 Investigations for effective risk management
By transitioning from initial risk identification to comprehensive root cause analysis, organizations can proactively address issues and implement lasting solutions.
The Current Good Manufacturing Practice for Finished Pharmaceuticals (211.192 production record reviews) requires the Quality Control team to review and approve the production of drug products and control records, including packaging and labelling. This is to ensure compliance with pre-established procedures before the release of a batch.
In case of unexpected discrepancies or in case a batch or any of its components does not meet the specifications outlined at the beginning, it should be thoroughly investigated, even if the batch has been distributed. Other batches of the same drug product or other drug products where a specific failure or discrepancy may have an impact must also be investigated. Even batches that are rejected based on an OOS result need to be investigated to see whether other batches of the same drug product or other products experience the same problems. A thorough, timely, unbiased, well-documented, and scientifically sound investigation needs to be done to identify the root cause and take necessary corrective and preventive action.
Usually, this is done in two phases – Phase I and Phase II.
The investigations happen in two parts.
During Phase 1 investigation, laboratory data is assessed, and an analyst and the supervisor verify initial preparation. This should preferably be done prior to test preparations (including the composite or the homogenous source of the aliquot tested) being discarded so that it can be used to test the hypotheses regarding laboratory error or instrument malfunctions.
The retained solutions should be examined during laboratory investigation, and the OOS test results should not be attributed to analytical error without the investigation being performed and documented.
Phase II is initiated when the initial investigation clears laboratory error as a possible cause for the OOS result. A comprehensive OOS investigation is initiated using a predefined procedure in case the testing results seem accurate, In this case, the investigation would include a review of the production process and/or additional work at the laboratory. The aim is to facilitate the identification of the root cause of the OOS result and initiate CAPA.
OOS and OOT investigations are an essential part of clinical testing and development, but it is a complicated process that…
In drug manufacturing quality control, a robust, well-defined testing and lab investigation process is critical to ensure that the drug…
What is a Safety Investigation? A safety investigation is a preventive action conducted to avoid accidents or near-misses. It is…
In Phase I, the retained solutions are examined as part of the laboratory investigation. This helps to ensure that the error is not due to faulty equipment/instrument or testing process and involves:
Documenting the investigation is another important component of Phase I investigation. In case of a cause is ascertained for the OOS during the investigation, it must be retested or recalculated. The results of the retest or recalculation must be documented and reported. If the results conform to the specifications the second time, then the initial data must be invalidated.
However, if a retest validates the initial results, then a full-scale OOS investigation should be performed using a predefined procedure.
In Phase II investigation, the components include:
The document must describe;
Hypothesis testing is initiated after completing the Analyst and Supervisor investigation and can include the original working stock solutions but not another preparation from the original sample. The original preparation or working solutions can be re-measured. It can be re-injected where transient equipment is suspected of malfunctioning. This is especially useful in identifying a malfunctioning instrument as the root cause. For dilution error, re-dilution of the original Solution can help. Investigational testing helps to confirm a probable cause rather than eliminate a suspect.
If the investigation reveals that the original sample was not appropriately prepared and therefore does not represent batch quality, a new and more accurate sampling method must be developed, documented, reviewed, and approved by the QCU.
Section 211.192 of the US Food and Drug Administration requires that whenever an OOS test result is obtained, an investigation must be conducted to establish the cause. It also requires the recording of the investigation made along with the conclusions and the follow-up action taken.
Section 211.165 stresses the importance of interpreting the investigation results. The results of Phase 1 and Phase 2 investigations must be analyzed and the batch evaluated before a decision is made to release or reject the batch.
Further, 211.165(f) requires the batch or lot quality to be evaluated to identify the cause of the OOS result. When the OOS result is confirmed, it is sufficient ground to reject the batch for not meeting the established standards or specifications.
According to 211.192, when the OOS cause is confirmed, an investigation of batch failure should be conducted on other batches or products that may be associated with the specific failure.
Current good manufacturing practice requires finished pharmaceuticals and active pharmaceutical ingredients (APIs) to be manufactured conforming to section 501(a)(2)(B) of the cGMP Act. Some of the key requirements for APIs include:
These tests support process validation and analytics. These regulations are encapsulated in CGMP regulations for laboratory operations and reflected in part 211, subparts I (Laboratory Controls) and J (Records and Reports). They enable establishing scientifically sound and appropriate specifications, standards, and test procedures for ensuring the conformation of components, in-process materials, containers and closures, and finished drug products with the established standards. The finished drug products that do not meet these standards, specifications, or other applicable quality control criteria will be rejected.
When an OOS result is obtained, it becomes important to ensure that the result is not a laboratory error, identify the true cause, and eliminate it to prevent future recurrence of non-conformance. In Phase I investigation, the focus is to eliminate laboratory error as a cause. The investigation progresses to Phase II when the cause is not a laboratory error, and a thorough investigation is undertaken to identify the causes in the production/manufacturing process.
Customer Success
The supervisor should conduct an objective and timely investigation without preconceived assumptions regarding the cause of the OOS result. Assess data to establish whether a laboratory error or a manufacturing process is causing it. The solutions, test units, and glassware used in the original measurements and preparations should be re-examined immediately to establish without doubt that laboratory error is the root cause.
During Phase 2 investigations, the following steps should be followed:
Production Review: The QCU should investigate in collaboration with other departments that could be implicated, such as manufacturing, process development, maintenance, and engineering. Even offsite manufacturing units should be investigated if there is a potential involvement and all potential problems identified and investigated. A complete review of records and documentation related to the manufacturing process is necessary. The review process should be recorded, covering the following information:
I’ve been using ComplianceQuest (CQ) for about 9 months and am extremely pleased with the product, the implementation team and ongoing support. I selected CQ for a number of reasons. Functionality and a simple user interface were key requirements. CQ has all the functionality needed in support of a global QMS. Implementation includes; Document control, change order, personnel training, NC/CAPA, equipment management, supplier management, audit management, and customer complaints all on a single platform. As a small biologics company it was critical to find a single solution to meet our GMP quality system requirements. We wanted a cloud-based system, that would be quick to implement, that could be expanded globally and in other languages, all for a reasonable price. The user interface – it is exactly what I was hoping for. I constantly hear the staff saying, “I love CQ, it’s so straightforward to use”.
The implementation team has met all my expectations. The CQ product ‘out of the box’ meets the majority of my requirements. With some minor configurations we have developed QMS workflows that are highly efficient and robust. A risk-based validation plan also allowed us to move quickly through the foundational functions; Controlled Documents, Change Order, and Personnel. The implementation team offer many industry best practices as solutions to questions and are also highly competent in listening to your requirements and doing whatever is necessary to fulfill them. Customer Support is incredibly timely in their responsiveness; addressing most questions or concerns within 24-48 hours, meanwhile communicating along the way. We are extremely happy with our selection and highly recommend ComplianceQuest.
Donna Matuizek,Sr. Director Quality
In today's complex regulatory environment, laboratories require robust software solutions that not only streamline investigative processes but also ensure full compliance with industry regulations. ComplianceQuest's Lab Investigation Software Solutions are designed to address these needs by offering an integrated platform that manages every aspect of laboratory investigations, from initial data capture to final reporting.
ComplianceQuest provides state-of-the-art solutions to help laboratories navigate the complex landscape of compliance and regulations efficiently. Our software is designed not just to assist in maintaining compliance but also to optimize lab operations to meet and exceed regulatory standards.
Implementing robust lab investigation software solutions not only streamlines laboratory processes but also ensures stringent adherence to laboratory compliance and regulations. ComplianceQuest's software offers a comprehensive suite of tools that empower labs to improve efficiency, enhance compliance, and ultimately drive innovation and success in their scientific endeavors.
Identification & Assessment of Out-Of-Specification (OOS) Test Results – Laboratory Investigation checklist
Checklist | July 12th, 2022
A checklist on Full scale OOS Investigation – Production (Part A)
A Checklist on Full-scale OOS Investigation – Retesting & Resampling (Part B)
A Checklist to Conclude OOS Investigation
A Checklist on Full scale OOS Investigation – Reporting Test Results
When an OOS result is obtained, Phase 1 of the investigation is initiated. During this phase, any possible cause in the laboratory is thoroughly investigated. If the error is not due to a laboratory error, then Phase 2 of the investigation is initiated. This is a more thorough review where all different aspects that could have caused the error are evaluated.
Automating the Phase 1 and Phase 2 investigations can improve the efficiency of the test results. It can help ensure the correct procedures are followed to meet regulatory requirements. Further, it also helps with collaboration between different teams, especially in Phase 2, when the QCU works with all relevant stakeholders, even in offsite locations.
Documentation is another regulatory requirement that can be easily handled with an automation solution such as ComplianceQuest’s cloud-based Laboratory Investigation Software.
The LIS is integrated with the CQ enterprise-wide quality management system. As a result, pharma companies can also leverage the CAPA solution that can be triggered when the cause is identified. This can help correct the issue and prevent its future recurrence.
Not only the affected batch, but tests may have to be conducted on other batches of the same product or other batches. The CQ solution helps to have greater visibility and access to data at every step to speed up OOS investigation for accurate results.
FDA inspections aren't just routine checks – they're the linchpin of pharmaceutical success. FDA inspections directly impact public health and company credibility. Understanding…
One of the five key questions leaders must ask themselves…
Section 21 CFR 211 of Current Good Manufacturing Practice (CGMP)…
Learn about all features of our Product, Quality, Safety, and Supplier suites. Please fill the form below to access our comprehensive demo video.
Please confirm your details
By submitting this form you agree that we can store and process your personal data as per our Privacy Statement. We will never sell your personal information to any third party.